lu.cabrera
TL2 · Dijon
Contributes reviews on supplier material. Based in Dijon.
Joined 31 December 2024 · last posted 13h
75 posts, newest first. Showing up to 150.
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #23 · Evidence › Journal club · 27 Jul 2026 · 0 likes STEP 8 is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Sulphur-smelling eructation: mechanism and what helps Replied, post #3 · Practice › Side effects · 27 Jul 2026 · 0 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
What is genuinely unknown about long-term amylin agonism Replied, post #82 · Compounds › Cagrilintide & amylin analogues · 25 Jul 2026 · 8 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #97 · Start Here › Welcome · 20 Jul 2026 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Seven-day rolling means and why weekly readings mislead Replied, post #27 · Outcomes › Progress reports · 14 Jul 2026 · 32 likes A seven-day rolling mean of daily readings has a much smaller standard error and makes most apparent plateaus and sudden drops disappear.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #57 · Nutrition & Training › Protein & intake · 12 Jul 2026 · 11 likes Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced. I have seen it…
-
What to include when your question involves a chromatogram — one year on Replied, post #59 · Start Here › How to Ask · 1 Jul 2026 · 0 likes Post #55 describes the usual case. This is about the unusual one. Context that matters: compound, how long in, current dose, relevant history. Context that does not…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #46 · Access › Insurance & coverage · 30 Jun 2026 · 0 likes Picking up post #45: that is the part I would want checked first. Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #48 · Evidence › Journal club · 20 Jun 2026 · 20 likes Building on post #45 rather than restating it. Practical experience of SURMOUNT-OSA, offered as one case with the conditions stated, not as a general finding.…
-
Aggregate verification data across the directory, with caveats Replied, post #3 · Sourcing › Independent verification · 18 Jun 2026 · 2 likes Narrowing post #2, because the general version has more than one answer. What I want from this aggregate verification data thread is the list of things that would need…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #10 · Access › Shortages · 7 Jun 2026 · 2 likes Post #7 put the caveat in the right place and I want to underline it. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages.…
-
Cold solution and stinging: the simplest fix Replied, post #26 · Practice › Administration · 18 May 2026 · 26 likes The documentation on cold solution and stinging is better than this thread and I say that as someone who has posted in the thread.
-
Official shortage notices and what they authorise Replied, post #52 · Access › Shortages · 16 May 2026 · 23 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #4 · Analytics › HPLC & UHPLC · 14 May 2026 · 0 likes Agreed on all of that, and I have nothing to add to it.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #59 · Practice › Administration · 8 May 2026 · 0 likes Worth stating the null on Rotating between abdomen before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #7 · Evidence › Trials · 6 May 2026 · 1 like Registration before enrolment, with the primary endpoint declared, is what makes outcome switching detectable. Checking the registry against the paper takes five…
-
Reading a home test result without over-claiming Replied, post #24 · Analytics › Home & field testing · 27 Apr 2026 · 25 likes Adding thanks rather than a view. I do not have a view worth the space.
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #30 · Outcomes › Progress reports · 24 Apr 2026 · 1 like Right, and stated more narrowly than I would have dared to state it.
-
About the COA interpretation category Replied, post #9 · Analytics › COA interpretation · 20 Apr 2026 · 20 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Journal club: is percentage weight change the right endpoint? Replied, post #76 · Evidence › Journal club · 17 Apr 2026 · 1 like SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #98 · Analytics › Mass spectrometry · 7 Apr 2026 · 0 likes The most useful thing anyone has posted about Adducts in this category was a table of what had been measured and by whom. That is what I would want again.
-
GLP-1 receptor distribution: central and peripheral Replied, post #21 · Pharmacology › Receptor biology · 25 Mar 2026 · 27 likes Post #18 is right about the mechanism and I think understates the practical bit. Ghrelin receptor agonism drives growth hormone release in pulses and also increases…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #46 · Outcomes › Body composition · 23 Mar 2026 · 16 likes Post #44 and I disagree about the size of the effect, not about the direction. Neither method is capable of detecting the month-to-month changes that people report…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #43 · Lounge › Introductions · 12 Mar 2026 · 3 likes Hello and welcome. One practical suggestion: watch two subcategories rather than the whole site. The firehose is real and it puts people off in the first fortnight.…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #63 · Outcomes › Body composition · 5 Mar 2026 · 6 likes Answering the question post #59 raises rather than the one it answers. Lean mass in these measurements includes water, so a change in hydration appears as a change in…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #6 · Pharmacology › Formulation chemistry · 3 Mar 2026 · 7 likes Where the Solubility limits reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #104 · Practice › Dosing & titration · 20 Feb 2026 · 1 like The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #13 · Practice › Interactions · 4 Feb 2026 · 32 likes Answering the question post #9 raises rather than the one it answers. The documentation on anaesthesia and elective surgery is better than this thread and I say that as…
-
Trifluoroacetate content and its consequences Replied, post #57 · Analytics › Impurities & related substances · 31 Jan 2026 · 4 likes A supplier that can tell you what its principal impurity is has answered a harder question than one that can tell you its purity, and the answer is more useful.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #35 · Documentation › Wiki requests · 12 Jan 2026 · 1 like Building on post #32 rather than restating it. The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems…
-
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Replied, post #8 · Compounds › Secretagogues & GH axis · 8 Jan 2026 · 33 likes On post #7 — agreed on the reasoning, with one qualification. Growth hormone secretagogues act on the ghrelin receptor or on the growth hormone releasing hormone…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #32 · Practice › Dosing & titration · 24 Dec 2025 · 15 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
[2026 update] What steady state means for the decision to escalate Replied, post #112 · Practice › Dosing & titration · 16 Nov 2025 · 18 likes Source for the steady state figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #22 · Meta › Announcements · 16 Nov 2025 · 0 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
-
Availability by country, dated, with primary sources Replied, post #33 · Access › International · 25 Oct 2025 · 0 likes What I would tell a new member reading about availability for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
New subcategory: rationale and scope Replied, post #51 · Meta › Announcements · 18 Oct 2025 · 0 likes Since new subcategory keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
What a 2 ppm match establishes, and what it does not Replied, post #60 · Analytics › Mass spectrometry · 16 Oct 2025 · 0 likes Resolution: "high resolution" commonly means I checked the source rather than the summary, and they differ.
-
Reading SURMOUNT-1 without the press release Replied, post #18 · Compounds › Tirzepatide · 27 Sep 2025 · 16 likes Building on post #16 rather than restating it. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive…
-
Titles that describe the question, not the situation Replied, post #102 · Start Here › How to Ask · 21 Sep 2025 · 1 like Post #100 describes the usual case. This is about the unusual one. It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #102 · Compounds › Retatrutide · 28 Aug 2025 · 26 likes I think the Triple agonism question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #83 · Compounds › Secretagogues & GH axis · 20 Aug 2025 · 3 likes Coming back to post #82, because the follow-up matters more than the original answer. Reconstitution volumes in this family are often small enough that dead volume in…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #6 · Documentation › Doc review · 13 Aug 2025 · 9 likes Agreed on evidence digest, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not,…
-
A request that was declined, and the reasoning — a second dataset Replied, post #60 · Documentation › Wiki requests · 12 Aug 2025 · 3 likes Say what would make the page wrong. A page whose failure conditions are stated is much easier to review honestly. A weak preference rather than a position.
-
Counter-ion content and its effect on measured mass Replied, post #106 · Analytics › Mass spectrometry · 29 Jul 2025 · 23 likes Post #103 is right about the mechanism and I think understates the practical bit. Sample preparation for mass spectrometry can itself introduce modifications,…
-
Washout: how long is long enough, and for what purpose Replied, post #46 · Pharmacology › Pharmacokinetics · 17 Jul 2025 · 4 likes Washout is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
[2026 update] Splitting an overlong document into two Replied, post #16 · Documentation › Wiki requests · 12 Jul 2025 · 12 likes No notes. Posting so the count is not one.
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #18 · Practice › Administration · 10 Jul 2025 · 11 likes Source for the Completing a dose figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than…
-
An appeal that failed, and what I would do differently Replied, post #7 · Access › Insurance & coverage · 7 Jul 2025 · 27 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 4 Jul 2025 · 2 likes Taking post #4 at face value and following it one step further. For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical…
-
Sequence verification for an obscure compound: how it is done Replied, post #74 · Compounds › Other compounds · 26 Jun 2025 · 5 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Revisiting: What to include when your question involves arithmetic Replied, post #5 · Start Here › How to Ask · 23 Jun 2025 · 0 likes Worth separating two things that post #4 runs together. Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and a…
-
Why a compound being unapproved is not the same as being illegal to possess Started this topic · Sourcing › Regulatory · 20 Jun 2025 · 0 likes Why a compound being unapproved is not the same as being illegal to possess I have a specific reason for asking rather than idle curiosity, and the context is below.…
-
When a preprint is the best available evidence and we say so — a second dataset Replied, post #25 · Evidence › Preprints · 10 Jun 2025 · 0 likes On post #21 — agreed on the reasoning, with one qualification. Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #115 · Devices › Cold chain · 2 Jun 2025 · 0 likes Post #112 describes the usual case. This is about the unusual one. I have three months of notes on Domestic fridge temperature mapping and the honest summary is that…
-
Lean mass preservation: what the evidence supports Replied, post #7 · Outcomes › Body composition · 7 May 2025 · 1 like Everything in post #5 holds. The case it does not cover is the one I have. An honest declaration on lean mass preservation: I have a prior here and it is strong enough…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #16 · Clinical › Bloodwork · 7 May 2025 · 4 likes Speaking only to Building a sensible monitoring schedule as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the…
-
Criticising the method without criticising the authors Replied, post #54 · Evidence › Study critique · 8 Apr 2025 · 0 likes A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is legitimate design and it must be stated in any summary.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #83 · Documentation › Doc review · 31 Mar 2025 · 1 like The useful distinction on draft on reconstitution arithmetic is between what was measured and what was inferred from it. Both end up in the same sentence and only one…
-
Reading order for a first week here, and what to skip until later Replied, post #42 · Start Here › Welcome · 18 Mar 2025 · 15 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #51 · Compounds › Secretagogues & GH axis · 16 Mar 2025 · 2 likes Picking up post #48: that is the part I would want checked first. The reason pulsatile secretion keeps being re-asked is that the answer is conditional and people quote…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #22 · Access › International · 1 Feb 2025 · 20 likes Post #20 and I disagree about the size of the effect, not about the direction. Where the Cross-border purchase within discussion usually stalls is that nobody wants to…
-
Why the Start Here categories exist, and what they are not for — one year on Replied, post #15 · Start Here › Welcome · 30 Jan 2025 · 23 likes Muting is under-used here. A category you mute stops appearing in Latest for you, and you can unmute it in a second. Most long-term members read four or five categories…
-
Second pass at: Albumin binding and how it produces a long half-life Replied, post #10 · Pharmacology › Pharmacokinetics · 26 Jan 2025 · 12 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Body image changing more slowly than the body Replied, post #95 · Wellbeing › Mental health · 21 Dec 2024 · 1 like Confirming post #93 from a second method, which matters more than confirming it from a second person. Body image has a well-known answer and a correct answer, and the…
-
Body image changing more slowly than the body Replied, post #74 · Wellbeing › Mental health · 19 Dec 2024 · 0 likes The practical version of body image is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
[2026 update] New subcategory: rationale and scope Replied, post #56 · Meta › Announcements · 10 Dec 2024 · 1 like Answering the question post #54 raises rather than the one it answers. The version of New subcategory that I was taught turned out to be a teaching simplification.…
-
Converting between mg/mL and units per dose, both directions Replied, post #94 · Practice › Reconstitution · 18 Nov 2024 · 0 likes This follows post #93 rather than contradicting it. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a…
-
EMA product information as a primary source — does this still hold? Replied, post #95 · Regional › European Union · 17 Nov 2024 · 5 likes Picking up post #93: that is the part I would want checked first. Small correction to my own earlier position on EMA product information. I had the units the wrong way…
-
A side-effect grading scheme this community uses, and its limits — the long version Replied, post #10 · Practice › Side effects · 13 Nov 2024 · 18 likes Confirming post #8 from a second method, which matters more than confirming it from a second person. The published rates come from populations that were titrated on a…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #90 · Practice › Administration · 8 Oct 2024 · 18 likes Taking post #88 at face value and following it one step further. I have three months of notes on site rotation scheme and the honest summary is that the trend is real…
-
Progressive overload when the scale is falling — one year on Replied, post #129 · Nutrition & Training › Resistance training · 6 Oct 2024 · 30 likes Progressive overload came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #74 · Analytics › COA interpretation · 4 Oct 2024 · 2 likes Peptide content and chromatographic purity are separate determinations and a certificate that reports only one has answered only one question. Content is the one that…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #33 · Evidence › Preprints · 2 Sep 2024 · 0 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim. One case,…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #5 · Start Here › Welcome · 2 Sep 2024 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Naming conventions for research peptides and the confusion they cause — one year on Replied, post #2 · Compounds › Other compounds · 11 Jul 2024 · 0 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…